| 发明名称 |
Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
| 摘要 |
The invention is directed to the use of a formulation comprising meloxicam or a pharmacologically acceptable meloxicam salt of an organic or inorganic base thereof for the long-term treatment of musculoskeletal disorders in cats. No negative effects on renal function occur following a treatment from 10 to 20 months or more. |
| 申请公布号 |
US9149480(B2) |
申请公布日期 |
2015.10.06 |
| 申请号 |
US201013581661 |
申请日期 |
2010.03.03 |
| 申请人 |
Boehringer Ingeleheim Vetmedica GmbH |
发明人 |
Johnston Laura |
| 分类号 |
A61K31/5415 |
主分类号 |
A61K31/5415 |
| 代理机构 |
|
代理人 |
Morris Michael P.;Morrison Joyce L. |
| 主权项 |
1. A method for the long-term treatment of musculoskeletal disorders in cats comprising administering to a cat an effective daily dose of meloxicam or a pharmaceutically acceptable meloxicam salt of an organic or inorganic base thereof, wherein the daily dose is greater than 0.05 mg/kg and no greater than 0.075 mg/kg and no acceleration of any existing renal disease in the cat or no initiation of any renal disease in the cat occurs during a treatment at the daily dose for a period of 13 to 40 months. |
| 地址 |
Ingeleheim am Rhein DE |
